ERK5 suppression overcomes FAK inhibitor resistance in mutant KRAS-driven non-small cell lung cancer

Chiara Pozzato(University of Bern), Georgia Konstantinidou(University of Bern)
EMBO Molecular Medicine
September 13, 2024
Cited by 10


Related Papers

Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy
|International Journal of Molecular Sciences|2019|155